Dx Deals: BD Laboratory Business Is Up for Grabs in Bold Move
Becton Dickinson divisions responsible for $3.4 billion in annual revenue are on the block
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Becton Dickinson divisions responsible for $3.4 billion in annual revenue are on the block
New policies aim to better protect data against increasing cyberattacks, but academics say the changes will limit critical research
How widespread is corruption in the lab—and what can be done to combat it?
Though potential FDA LDTs regulation has drawn a lot of attention, other efforts could also have long-term effects on how labs do business.
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
The ALZpath DX assay is less invasive than other diagnostic tests, and may give patients diagnosed with Alzheimer’s more time to plan
The impending legislation that may determine Medicare lab fees from 2025 onward
Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.
Formulating queries that are compliant, informative, and effective—even in tricky situations.
Program outlined in a recently introduced bill would test AI’s effectiveness in detecting suspect payments for diagnostic tests and DME.